H2A — H2APEX SCA Income Statement
0.000.00%
- €70.17m
- €98.01m
- €29.57m
Annual income statement for H2APEX SCA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 3.85 | 15.3 | 29.6 |
Cost of Revenue | |||||
Gross Profit | — | — | 0.73 | 1.66 | 0.892 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.74 | 1.14 | 14.4 | 37.5 | 55.1 |
Operating Profit | -1.74 | -1.14 | -10.5 | -22.2 | -25.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.982 | -2.22 | -13.9 | -24.2 | -27.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.23 | -2.22 | -13 | -24.6 | -27.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.11 | 87.1 | -12.9 | -24.7 | -27.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.11 | 87.1 | -12.9 | -24.7 | -27.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.061 | -0.111 | -0.645 | -0.667 | -0.711 |
Dividends per Share |